Risk-Adapted Strategy Combining Magnetic Resonance Imaging and Prostate-Specific Antigen Density to Individualize Biopsy Decision in Patients With PI-RADS 3 ``Gray Zone'' Lesions

Recent guidelines suggest that biopsy may be omitted in some groups of patients with PI-RADS 3 lesions on mpMRI. In this study, we aimed to evaluate biopsy strategies involving prostate-specific antigen density (PSAd) to avoid unnecessary biopsy versus the risk of missing clinically significant pros...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical genitourinary cancer 2024-06, Vol.22 (3), p.102071-102071, Article 102071
Hauptverfasser:	Akpinar, Cagri, Oz, Digdem Kuru, Oktar, Alkan, Suer, Evren, Ozden, Eriz, Haliloglu, Nuray, Gulpinar, Omer, Gokce, Mehmet Ilker, Gogus, Cagatay, Baltaci, Sumer
Format:	Artikel
Sprache:	eng
Schlagworte:	Diagnostic performance Individualized prostate biopsy Prostate cancer PSA-density Risk-adapted approach
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!